Equipment and Services Health Care Equipment and Supplies

  • NEW YORK, Oct 20- Bullish options on Varian Medical Systems Inc stock saw unusually heavy buying on Thursday before the shares spiked on an unsubstantiated report that General Electric could be in talks with the medical devices company about a possible takeover. Roughly 2,100 Varian Medical Systems call contracts betting on the shares rising above $100 by...

  • Jude by the end of the year and praised the smaller company's handling of claims by short-seller Muddy Waters that its implantable heart devices posed cyber security risks. Shares of Abbott fell 2.7 percent to $40.04 while Alere rose 2.3 percent to $43.36 and St. Jude dipped 0.6 percent to $79, all on the New York Stock Exchange.

  • Jude Medical Inc for $25 billion, reported third-quarter results that nudged past Wall Street estimates, driven by strength in its medical devices business. The company narrowed its adjusted profit from continuing operations forecast to a range of $2.19 to $2.21 per share from $2.14 to $2.24. Abbott reported a net loss from continuing operations of $329...

  • Jude said in a statement that the group, known as the Cyber Security Medical Advisory Board, would provide advice on cyber security standards for medical devices. The FDA launched that probe in August after short-seller Muddy Waters and cyber research firm MedSec Holdings said they had placed bets that St. "We take the cyber security of our devices very...

  • Jude Medical Inc on Tuesday said it would recall some of its 400,000 implanted heart devices due to risk of premature battery depletion, a condition linked to two deaths in Europe. All the devices, called ICDs and CRT-Ds, contain batteries that were manufactured before May 23, 2015, when the company added insulation to reduce the chance of an electrical short...

  • Jude Medical Inc on Tuesday said it would recall some of its implanted heart devices due to risk of premature battery depletion, a condition linked to two deaths in Europe. All contain batteries that were manufactured before May 23, 2015, when the company added insulation to reduce the chance of an electrical short circuit. Jude's vice president of quality...

  • Oct 6- Pfizer Inc said on Thursday it would sell its global infusion therapy business to ICU Medical Inc for $1 billion in cash and stock that will give it a major stake in the smaller company. Pfizer had acquired the hospital infusion system business, which has annual sales of about $1.2 billion, through its $15 billion purchase in September 2015 of Hospira, which...

  • Oct 6- Pfizer Inc said on Thursday it would sell its global infusion therapy business, part of its $15 billion Hospira acquisition last year, to ICU Medical Inc for $1 billion in cash and stock. Pfizer had acquired the hospital infusion systems, which have annual sales of about $1.2 billion, through its purchase in September 2015 of Hospira, which sells generic...

  • Oct 6- Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems, for $1 billion in cash and stock. Pfizer will receive $600 million in cash and nearly $400 million in newly issued shares of ICU Medical common stock, giving the drugmaker a stake of about 16.6 percent. Skadden, Arps, Slate, Meagher&...

  • J&J warns of cybersecurity issue with insulin pump

    CNBC's Meg Tirrell reports the latest details surrounding Johnson & Johnson and the cyber hack of one of the company's medical devices. Jay Radcliffe, Rapid7 senior security consultant, weighs in.

  • TORONTO, Oct 3- Canada's main stock index fell on Monday, as major gold miners lost ground and heavyweight banks also pulled back as the federal government tightened mortgage and tax rules in a bid to cool the housing market. The most influential stocks weighing on the index included Goldcorp Inc which fell 4.5 percent to C $20.68 after it temporarily shut down...

  • Oct 3- Spectral Medical Inc said its experimental treatment for sepsis- a common, oft-deadly complication of infection- failed a late-stage study, stymieing the company's plans to bring to market the first FDA- approved device for the condition. "We proved beyond doubt that endotoxin is bad and taking it out is good," and Spectral will discuss with the U.S. Food and...

  • Oct 3- Spectral Medical Inc said its experimental treatment for sepsis- a common, oft-deadly complication of infection- failed a late-stage study, stymieing the company's plans to bring to market the first FDA- approved device for the condition. There are no specific FDA- approved medicines for the treatment of sepsis, and there have been several high-profile...

  • The U.S. Food and Drug Administration, in its approval of the device, the MiniMed 670 G, hailed it as a breakthrough. Jeffrey Shuren, director of the FDA's medical device division, said in a statement. Analysts said the FDA approved the device six months sooner than expected.

  • Sept 28- The U.S. Food and Drug Administration on Wednesday approved Medtronic Plc's "artificial pancreas" designed to automatically deliver the right dose of insulin to patients with type 1 diabetes. Jeffrey Shuren, director of the FDA's medical device division said in a statement. "This device will mean peace of mind, in knowing a person will be in normal blood...

  • Sept 8- Medical device maker Abbott Laboratories and Alere Inc agreed on Thursday to work with a mediator to settle their dispute over Abbott's role in obtaining U.S. antitrust clearance for its $5.8 billion takeover of the diagnostics company, but Alere voiced concern about the speed of the process. The companies are considering using former Delaware...

  • Jude Medical Inc on Wednesday sued short-selling firm Muddy Waters and cybersecurity company MedSec Holdings Ltd, saying they intentionally disseminated false information about its heart devices to manipulate its stock. Muddy Waters, run by Carson Block, said in late August that St. A spokesman for Muddy Waters and MedSec said in an emailed statement, "It is...

  • Jude Medical Inc on Wednesday filed a lawsuit against short-selling firm Muddy Waters and cyber security company MedSec Holdings Ltd, saying they intentionally disseminated false information about its heart devices to manipulate its stock. Jude's shares fell sharply on Aug. 25 after Muddy Waters, run by Carson Block, said it had taken a short position in...

  • Sept 6- Danaher Corp said on Tuesday it would buy molecular diagnostics company Cepheid in a deal valued at $4 billion, including debt, to strengthen its diagnostics business. Danaher will pay $53 per share in cash, a premium of 54 percent to Cepheid's close of $34.42 on Friday. 1/ 8 nPn10sKcxa. Cepheid had revenue of $539 million last year, and is expecting $618...

  • Aug 31- Tecomet Inc, a privately held U.S. contract manufacturer of medical devices and surgical instruments, is exploring a sale that could value it at more than $1 billion, including debt, according to people familiar with the matter. Genstar Capital, the private equity firm that owns Tecomet, has hired investment bank William Blair& Company, LLC to run an auction...